Volatile organic compounds in exhaled breath of patients with COPD ± lung cancer and their correlation with FEV1-values

M. Westhoff, P. Litterst, H. Sommer, B. Bödecker, J. I. Baumbach (Hemer, Münster, Dortmund, Reutlingen, Germany)

Source: International Congress 2014 – The assessment of comorbidities
Session: The assessment of comorbidities
Session type: Thematic Poster Session
Number: 987
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Westhoff, P. Litterst, H. Sommer, B. Bödecker, J. I. Baumbach (Hemer, Münster, Dortmund, Reutlingen, Germany). Volatile organic compounds in exhaled breath of patients with COPD ± lung cancer and their correlation with FEV1-values. Eur Respir J 2014; 44: Suppl. 58, 987

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Differences in volatile organic compounds (VOC) determined in exhaled breath in two populations of lung cancer (LC): With and without COPD
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013


Using exhaled breath profiles in the discrimination between COPD, lung cancer and their co-morbidity
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015

Volatile organic compounds in COPD: Is hexanal an inflammation biomarker?
Source: International Congress 2016 – The future of lung function is beginning now
Year: 2016


Volatile organic compounds of exhaled breath in lung cancer and lung inflammatory diseases
Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer
Year: 2013


Analysis of exhaled air for a rapid, sensible and specific diagnosis of COPD
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015

Exhaled particles from small airways in COPD patients – A pilot study
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014

Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013

Exhaled breath condensate hydrogen peroxide in obstructive airways disease
Source: International Congress 2014 – Airway biomarkers
Year: 2014


Unbiased clustering of severe asthma patients based on exhaled breath profiles
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015

Double-tracer gas washout in stable asthma and COPD
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014


The analysis of breath air by laser spectroscopy method for diagnosis of COPD
Source: International Congress 2014 – Airway biomarkers
Year: 2014

Breath volatile organic compound (VOC) COPD study at two DZL centers - Evaluation of site-specific VOC
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015

Monitoring exhaled carbon monoxide in COPD exacerbations
Source: International Congress 2014 – Airway biomarkers
Year: 2014

Changes in PH of exhaled breath condensate after specific inhalation challenge test, in patients with hypersensitivity pneumonitis
Source: International Congress 2014 – ILDs 3
Year: 2014

Volatile organic compounds in exhaled breath samples as potential biomarkers in early diagnosis of lung cancer – (Ege translational pulmonology research group [EgeTPAG])
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016

Exhaled breath condensate biomarkers in COPD
Source: Eur Respir J 2008; 32: 472-486
Year: 2008



Hydrogen sulfide (H2S) in sputum and serum as a novel biomarker of COPD
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014

Identification of exhaled volatile organic compounds (VOCs) associated with loss of asthma control
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016

Analysis of semi-volatile organic compounds in exhaled breath condensate of patients with obstructive lung diseases
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010

The impact of acute smoke exposure on selected biomarkers in exhaled breath condensate in COPD patients and healthy smokers
Source: International Congress 2016 – Molecular pathways of smoking-induced diseases
Year: 2016